Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients. The gene discussed is NRGN; the disease is early-onset autosomal dominant Alzheimer disease.